Up & Running with Andy Pfahnl of Kobara Medical, a gBETA Medtech Company

June 6  

gener8tor, a nationally ranked accelerator program, has partnered with Boston Scientific to launch a healthcare-focused program in Medical Alley. Over the next few weeks, we will profile the first cohort of companies.

Andy has held Manager, VP, GM and CTO positions at Devicix/Nortech, Amphenol, and Teradyne. He is leading the product commercialization at CathVision ApS and teaches at the University of St. Thomas. He holds ScD & MS degrees from MIT and a BS degree from RPI.

What does Kobara Medical do? 

Kobara Medical designs and manufactures cardiac rhythm management (CRM) and neuromodulation devices.

How does it make a difference in healthcare? 

Kobara’s cardiac lead technology is a single solution to treat heart failure and cardiac arrhythmias.

What motivated you to take on this issue? 

Physician cofounder’s vision of an elegant solution to the CRM limitations particularly in effectiveness, since the evolution of CRM has not scaled with the complexity of the required therapy.

Why gBETA? 

They are an energetic and dynamic team that is passionate about helping startups. This program is local, no cost, intense (7 weeks) and efficient, providing lots of great candid coaching.

gBETA Medtech is a free, seven-week accelerator that works with medical device, healthcare-related software, biotech and diagnostics startups. Part of gener8tor, a nationally ranked accelerator program, gBETA Medtech is in partnership with Boston Scientific and supported by the Mayo Clinic and the University of Minnesota. For more information visit https://www.gbetamedtech.com/

Success message!
Warning message!
Error message!